Hantech Bio-Technology Co., Ltd. · TPEX:1294

Hantech Bio-Technology Co., Ltd. financial statements

Hantech Bio-Technology Co., Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue778.5M748.4M625.1M302.5M240.3M
Cost of revenue489.6M442.7M344.3M175.9M139.3M
Gross profit288.9M305.7M280.9M126.6M101.0M
Research and development12.2M10.1M7.37M8.09M6.90M
Selling, general and administrative103.2M98.2M88.3M61.1M55.5M
Operating income173.6M197.4M185.1M57.4M38.6M
Depreciation and amortization38.2M32.1M20.9M19.3M18.7M
EBITDA211.7M229.5M206.1M76.8M57.3M
Interest expense2.98M5.38M2.12M1.47M1.55M
Income before tax173.0M194.6M184.6M57.7M38.4M
Net income139.1M155.7M148.1M47.5M32.6M
Earnings per share, basic3.835.125.341.451.19

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents249.4M382.4M167.1M75.0M86.4M
Short-term investments90.0M
Receivables130.1M73.3M82.0M50.1M24.9M
Inventory108.3M63.3M77.2M26.7M18.5M
Current assets591.5M534.6M339.9M158.7M135.2M
Total assets1.17B1.12B930.9M473.6M375.6M
Accounts payable115.7M46.3M99.2M33.7M13.7M
Current liabilities246.5M192.2M224.3M96.7M67.3M
Long-term debt69.3M92.3M285.1M84.5M110.4M
Total liabilities334.1M298.2M529.6M205.0M197.7M
Shareholders' equity829.2M817.8M398.1M266.9M174.6M
Shares outstanding36.3M30.4M27.7M32.9M27.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations160.6M150.8M191.9M63.2M44.4M
Capital spending-16.7M-25.4M-297.2M-83.6M-80.3M
Free cash flow143.9M125.4M-105.3M-20.4M-35.9M
Dividends paid-87.4M-19.4M-16.8M-8.06M
Share buybacks-69.4M0
Change in cash-133.0M215.3M92.0M-11.4M4.63M